Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEBRIKIZUMAB Cause Conjunctivitis? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Conjunctivitis have been filed in association with LEBRIKIZUMAB (EBGLYSS). This represents 10.3% of all adverse event reports for LEBRIKIZUMAB.

8
Reports of Conjunctivitis with LEBRIKIZUMAB
10.3%
of all LEBRIKIZUMAB reports
0
Deaths
2
Hospitalizations

How Dangerous Is Conjunctivitis From LEBRIKIZUMAB?

Of the 8 reports, 2 (25.0%) required hospitalization.

Is Conjunctivitis Listed in the Official Label?

Yes, Conjunctivitis is listed as a known adverse reaction in the official FDA drug label for LEBRIKIZUMAB.

What Other Side Effects Does LEBRIKIZUMAB Cause?

Treatment failure (9) Asthma (7) Erythema (6)

What Other Drugs Cause Conjunctivitis?

DUPILUMAB (5,270) ADALIMUMAB (457) METHOTREXATE (385) ETANERCEPT (306) PREDNISONE (250) SECUKINUMAB (237) RITUXIMAB (222) SULFAMETHOXAZOLE\TRIMETHOPRIM (218) INFLIXIMAB (212) LAMOTRIGINE (199)

Related Pages

LEBRIKIZUMAB Full Profile All Conjunctivitis Reports All Drugs Causing Conjunctivitis LEBRIKIZUMAB Demographics